This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging ...

The S&P 500 slipped 0.3% on Tuesday, Nov. 12, the benchmark index's first negative trading day since last week's election.

Robert W. Baird has recently reduced DexCom Inc (DXCM) stock to Neutral rating, as announced on July 26, 2024, according to Finviz. Earlier, on July 26, 2024, JP Morgan had reduced the stock from a ...

Shares of DexCom Inc. DXCM inched 0.44% higher to $68.91 Thursday, on what proved to be an all-around mixed trading session ...

Over the last 12 months DXCM shares have declined by -15.9%, which represents a difference of -54.9% when compared to the S&P 500. The stock's 52 week high is $142.0 per share and its 52 week low is ...

Wells Fargo analysts published their “Growth List.” These are companies – benchmarked against the Russell Midcap Growth Index ...

StockNews.com lowered shares of DexCom (NASDAQ:DXCM – Free Report) from a buy rating to a hold rating in a research report report published on Saturday. A number of other analysts have also weighed in ...

Aristotle Focus Growth Strategy highlighted stocks like DexCom, Inc. (NASDAQ:DXCM), in the third quarter 2024 investor letter ...

On Wednesday, DexCom Inc (DXCM) stock saw a decline, ending the day at $71.8 which represents a decrease of $-0.44 or -0.61% from the prior close of $72.24. The stock opened at $72.1 and touched a low ...

We recently published a list of the 10 Worst Performing Stocks in S&P 500 in 2024. In this article, we are going to take a ...

Investment advisory firm Ithaka Group released the “Ithaka US Growth Strategy” third-quarter 2024 investor letter. A copy of ...

DexCom (NASDAQ:DXCM – Free Report) had its price objective boosted by Wells Fargo & Company from $80.00 to $90.00 in a ...